West Pharmaceutical Services | WST - Pre Tax Profit


West Pharmaceutical Services reported $180.1M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Align Technology USD 148.69M 193K Jun/2026
Baxter International USD 362M 368M Jun/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Cerus USD -20.76M 17.9M Dec/2024
Charles River Laboratories USD -29.94M 264.16M Mar/2026
Cooper Companies USD 192.2M 75.4M Dec/2025
Dentsply International USD -42M 105M Mar/2026
Haemonetics USD 47.57M 75.97M Jun/2026
ICU Medical USD -3.97M 11.93M Mar/2026
Insulet USD 118.7M 5.7M Jun/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
J&J USD 8.66B 839M Jun/2026
Medtronic USD 2.45B 1.04B Mar/2026
Merit Medical Systems USD 53.55M 2.49M Mar/2026
Neogen USD -20.3M 48.3M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Quidel USD -79.5M 32.9M Mar/2026
Repligen USD 14.15M 12.38M Jun/2026
Rockwell Medical USD 343K 2.07M Jun/2024
Solventum Corp USD 332M 179M Dec/2025
STAAR Surgical USD -20.65M 39.44M Dec/2025
Terumo JPY 90.32B 58.66B Jun/2026
Utah Medical Products 418K 3K Sep/2024
West Pharmaceutical Services USD 180.1M 18.6M Mar/2026